Skip to content

D&A at other companies

Baxter International logo
Baxter InternationalBAX
$237M-4.0%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$209K-15.7%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$30.5M+4.1%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$19.8M+1.5%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Nordson logo
NordsonNDSN

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's D&A?
KORU Medical Systems (KRMD) reported D&A of $197.53K in Q1 2026.
How has KORU Medical Systems's D&A changed year-over-year?
KORU Medical Systems's D&A decreased by 9.1% year-over-year, from $217.36K to $197.53K.
What is the long-term trend for KORU Medical Systems's D&A?
Over 4 years (2021 to 2025), KORU Medical Systems's D&A has grown at a 15.0% compound annual growth rate (CAGR), from $463.13K to $810.5K.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.